Skip to main content
Fig. 6 | Virology Journal

Fig. 6

From: Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease

Fig. 6

AYA2012004_L does not affect body weight of mice. C57BL/6J mice administered with 200 ul of DPBS in the absence or presence of AYA2012004_L and ODN 1826 via bronchoalveolar lavage. Mice body weight were measured one day before treatment (on day 0) and on day 44 (24 hrs before study termination). The data is expressed as a percent value of the normalization to DPBS treated mice. The p values were determined with one-way ANOVA, Tukey’s multiple comparisons test. ns: denotes nonsignificant.

Back to article page

Virology Journal

ISSN: 1743-422X